> PUBLICATION > Research Paper

Research Paper
[Nature Communications, 2024] Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer

Release Time:2025-12-26

Hits:

Title of Paper:[Nature Communications, 2024] Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer

Translation or Not:No

Release Time:2025-12-26

Prev One:[Science Advances, 2024] Epigenetic regulation of p63 blocks squamous-to-neuroendocrine transdifferentiation in esophageal development and malignancy

Next One:[Science China Life Sciences, 2024] Genes and proteins expressed at different life cycle stages in the model protist Euplotes vannus revealed by both transcriptomic and proteomic approaches